Clinical trial
Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III…
NCT00004227 · University of Alabama at Birmingham, Other · Terminated
Key facts
| NCT number | NCT00004227 |
|---|---|
| Title | Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx |
| Official title | Randomized Phase III Trial to Compare Radiation Therapy Alone With Radiation Therapy and Concomitant Anti-EGFr Antibody (C225) for Locally Advanced Squamous Cell Carcinomas of the Head and Neck |
| Lead sponsor | University of Alabama at Birmingham, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Procedure, Radiation |
| Interventions | cetuximab, conventional surgery, radiation therapy |
| Enrollment | 32 |
| Start date | Apr 1, 1999 |
| Primary completion | Mar 1, 2007 |
| Completion | May 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Feb 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: